Michael Dunne

2.0k total citations
31 papers, 1.5k citations indexed

About

Michael Dunne is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Michael Dunne has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomaterials, 15 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Michael Dunne's work include Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Medical Imaging Techniques and Applications (4 papers). Michael Dunne is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Medical Imaging Techniques and Applications (4 papers). Michael Dunne collaborates with scholars based in Canada, United States and Netherlands. Michael Dunne's co-authors include Christine Allen, David A. Jaffray, Alexandros Marios Sofias, Gert Storm, Maximilian Regenold, Jinzi Zheng, James Stewart, Devika B. Chithrani, Shawn Stapleton and Faquan Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and PLoS ONE.

In The Last Decade

Michael Dunne

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Dunne Canada 19 695 691 415 209 176 31 1.5k
Susanne K. Golombek Germany 7 724 1.0× 616 0.9× 430 1.0× 236 1.1× 107 0.6× 7 1.3k
Mami Murakami Canada 7 713 1.0× 904 1.3× 490 1.2× 172 0.8× 115 0.7× 8 1.4k
Lia Appold Germany 10 894 1.3× 627 0.9× 390 0.9× 281 1.3× 111 0.6× 12 1.4k
Jennifer I. Hare United Kingdom 9 585 0.8× 737 1.1× 417 1.0× 156 0.7× 74 0.4× 12 1.2k
Jurstine Daruwalla Australia 11 453 0.7× 671 1.0× 441 1.1× 150 0.7× 109 0.6× 17 1.3k
Iwona T. Dobrucki United States 17 578 0.8× 419 0.6× 531 1.3× 184 0.9× 227 1.3× 36 1.9k
Sijumon Kunjachan United States 18 953 1.4× 778 1.1× 474 1.1× 332 1.6× 258 1.5× 28 1.8k
Edgar Pérez‐Herrero Spain 16 760 1.1× 771 1.1× 707 1.7× 215 1.0× 124 0.7× 21 1.9k
Kyoung Sub Kim South Korea 17 714 1.0× 578 0.8× 394 0.9× 389 1.9× 204 1.2× 37 1.5k
Chase W. Kessinger United States 23 533 0.8× 552 0.8× 655 1.6× 301 1.4× 316 1.8× 39 1.8k

Countries citing papers authored by Michael Dunne

Since Specialization
Citations

This map shows the geographic impact of Michael Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dunne more than expected).

Fields of papers citing papers by Michael Dunne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dunne. The network helps show where Michael Dunne may publish in the future.

Co-authorship network of co-authors of Michael Dunne

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Dunne. A scholar is included among the top collaborators of Michael Dunne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Dunne. Michael Dunne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curreri, Alexander M., et al.. (2024). Localization of Intramuscular mRNA Delivery Using Deep Eutectic‐Lipid Nanocomposites. Advanced Healthcare Materials. 13(20). e2400327–e2400327. 8 indexed citations
2.
Kapate, Neha, Michael Dunne, Vineeth Chandran Suja, et al.. (2024). Polymer Backpack‐Loaded Tissue Infiltrating Monocytes for Treating Cancer. Advanced Healthcare Materials. 14(5). e2304144–e2304144. 12 indexed citations
3.
4.
Curreri, Alexander M., Jayoung Kim, Michael Dunne, et al.. (2023). Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics. Advanced Science. 10(7). e2205389–e2205389. 25 indexed citations
5.
Dunne, Michael, et al.. (2021). Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro. Scientific Reports. 11(1). 11103–11103. 11 indexed citations
6.
Dunne, Michael, Maximilian Regenold, & Christine Allen. (2020). Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy. Advanced Drug Delivery Reviews. 163-164. 98–124. 111 indexed citations
7.
Regenold, Maximilian, et al.. (2020). Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine. Journal of Controlled Release. 328. 551–561. 14 indexed citations
8.
Dunne, Michael, et al.. (2019). Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies. Journal of Controlled Release. 308. 197–208. 45 indexed citations
9.
Stapleton, Shawn, Michael Dunne, Michael Milosevic, et al.. (2018). Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics. ACS Nano. 12(8). 7583–7600. 65 indexed citations
10.
11.
Cui, Lei, Sohyoung Her, Michael Dunne, et al.. (2017). Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts. Radiation Research. 187(2). 147–160. 46 indexed citations
12.
Dou, Yannan N., Naz Chaudary, Martin C. Chang, et al.. (2017). Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma. Journal of Controlled Release. 262. 182–191. 17 indexed citations
13.
Ekdawi, Sandra N., James Stewart, Michael Dunne, et al.. (2015). Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model. Journal of Controlled Release. 207. 101–111. 73 indexed citations
14.
Abah, Udo, Michael Dunne, Andrew Cook, et al.. (2015). Does quality of life improve in octogenarians following cardiac surgery? A systematic review. BMJ Open. 5(4). e006904–e006904. 36 indexed citations
15.
Stapleton, Shawn, Michael Milosevic, Christine Allen, et al.. (2013). A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors. PLoS ONE. 8(12). e81157–e81157. 73 indexed citations
16.
Zheng, Jianfeng, Dmitri B. Kirpotin, Michael Dunne, et al.. (2012). Abstract P4-02-05: A novel 64Cu-liposomal PET agent (MM-DX-929) predicts response to liposomal chemotherapeutics in preclinical breast cancer models. Cancer Research. 72(24_Supplement). P4–2. 1 indexed citations
17.
Dunne, Michael, Jinzi Zheng, Joshua D. Rosenblat, David A. Jaffray, & Christine Allen. (2011). APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. Journal of Controlled Release. 154(3). 298–305. 74 indexed citations
18.
Chithrani, Devika B., Michael Dunne, James Stewart, Christine Allen, & David A. Jaffray. (2009). Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier. Nanomedicine Nanotechnology Biology and Medicine. 6(1). 161–169. 142 indexed citations
19.
Zheng, Jinzi, Jubo Liu, Michael Dunne, David A. Jaffray, & Christine Allen. (2007). In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications. Pharmaceutical Research. 24(6). 1193–1201. 90 indexed citations
20.
English, Judie, Michael Dunne, & V. Marks. (1983). Diurnal variation in prednisolone kinetics. Clinical Pharmacology & Therapeutics. 33(3). 381–385. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne K. Golombek Breakdown of academic impact, for papers by Mami Murakami Breakdown of academic impact, for papers by Lia Appold Breakdown of academic impact, for papers by Jennifer I. Hare Breakdown of academic impact, for papers by Jurstine Daruwalla Breakdown of academic impact, for papers by Iwona T. Dobrucki Breakdown of academic impact, for papers by Sijumon Kunjachan Breakdown of academic impact, for papers by Edgar Pérez‐Herrero Breakdown of academic impact, for papers by Kyoung Sub Kim Breakdown of academic impact, for papers by Chase W. Kessinger
Rankless by CCL
2026